TY - JOUR
T1 - Skin cream for alleviating seat pain in amateur long-distance bicyclists
AU - Weiss, Barry D.
N1 - Funding Information:
The author thanks Carole Adler, RN, and Dianne Ferrera for their valuable contributions to this research project. The author also thanks the Greater Arizona Bicycling Association and Richard Case, OD, tour director, for facilitating this research. This research was supported by a grant from the Thompson Medical Company, New York, N.Y.
PY - 1993/6/1
Y1 - 1993/6/1
N2 - Seat pain is common among amateur bicyclists, who often self-treat seat pain with skin creams. This research evaluates the efficacy of two commonly used creams, compared with a placebo, for preventing bicycle-related seat pain. Studied were 188 adults participating in a 500 mile, week-long amateur bicycle trip. Participants were randomly allocated to receive 0.5% hydrocortisone cream, 10% trolamine salicylate cream, or a nonmedicated placebo cream, in a double-blind fashion. Each cyclist applied cream to his seat area skin twice daily. After the ride, cyclists were evaluated to determine severity of their seat pain and presence of skin breakdown. The data were analyzed to determine if these outcomes differed among the three groups. Overall, 84.9% of the participants experienced seat pain and 6.9% had seat area skin breakdown, but there were no significant differences among the three cream groups. These results show that hydrocortisone (0.5%) or trolamine salicylate (10%) creams are no more effective than placebo for preventing bicycle-related seat pain.
AB - Seat pain is common among amateur bicyclists, who often self-treat seat pain with skin creams. This research evaluates the efficacy of two commonly used creams, compared with a placebo, for preventing bicycle-related seat pain. Studied were 188 adults participating in a 500 mile, week-long amateur bicycle trip. Participants were randomly allocated to receive 0.5% hydrocortisone cream, 10% trolamine salicylate cream, or a nonmedicated placebo cream, in a double-blind fashion. Each cyclist applied cream to his seat area skin twice daily. After the ride, cyclists were evaluated to determine severity of their seat pain and presence of skin breakdown. The data were analyzed to determine if these outcomes differed among the three groups. Overall, 84.9% of the participants experienced seat pain and 6.9% had seat area skin breakdown, but there were no significant differences among the three cream groups. These results show that hydrocortisone (0.5%) or trolamine salicylate (10%) creams are no more effective than placebo for preventing bicycle-related seat pain.
KW - bicycle
KW - overuse syndromes
UR - http://www.scopus.com/inward/record.url?scp=0027248297&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027248297&partnerID=8YFLogxK
U2 - 10.1080/15438629309511963
DO - 10.1080/15438629309511963
M3 - Article
AN - SCOPUS:0027248297
SN - 1057-8315
VL - 4
SP - 27
EP - 32
JO - Sports Medicine, Training and Rehabilitation
JF - Sports Medicine, Training and Rehabilitation
IS - 1
ER -